SAMD4B and breast cancer: RT-qPCR analysis results demonstrated that knockdown of SAMD4B significantly downregulated β-catenin mRNA level, whereas its overexpression markedly upregulated β-catenin mRNA expression in breast cancer cells (Figure 6E).